Ipamorelin GHSR-1a Research: GH Axis Signalling and Receptor Pharmacology Studies

Ipamorelin GHSR-1a Research: GH Axis Signalling and Receptor Pharmacology Studies

Ipamorelin GHSR-1a Research: GH Axis Signalling and Receptor Pharmacology Studies

Research Overview

Ipamorelin represents a synthetic pentapeptide investigated extensively in cell-based assay formats for its selective growth hormone secretagogue receptor-1a (GHSR-1a) activation properties. This compound demonstrates distinct receptor pharmacology characteristics through its interaction with class A G-protein coupled receptors, specifically triggering Gq/11-mediated calcium mobilization pathways. Published in vitro research characterizes its molecular interactions, binding affinity profiles, and downstream signaling cascade engagement in defined cell model systems under controlled laboratory conditions.

The compound's pentapeptide structure enables selective receptor targeting while maintaining stability in cell culture environments, making it valuable for mechanistic studies investigating growth hormone axis regulation at the cellular level.

Receptor Pharmacology and Mechanism of Action

GHSR-1a Binding Characteristics

Ipamorelin demonstrates high-affinity binding to GHSR-1a receptors through competitive radioligand binding assays. The compound exhibits nanomolar binding affinity (Ki values typically ranging 0.1-1.0 nM in cell membrane preparations), indicating strong receptor selectivity compared to other growth hormone secretagogue compounds. Saturation binding studies reveal single-site binding kinetics with Hill coefficients approaching unity, suggesting non-cooperative binding interactions.

Competitive displacement experiments using [125I]-labeled growth hormone-releasing peptide demonstrate that ipamorelin effectively competes for GHSR-1a binding sites with IC50 values consistent with its measured binding affinity. Kinetic binding studies indicate relatively slow dissociation rates, contributing to sustained receptor occupancy in cell-based experimental systems.

G-Protein Coupling and Signal Transduction

Functional cell-based assays demonstrate that ipamorelin activates GHSR-1a through preferential coupling to Gq/11 G-protein subunits. This coupling mechanism triggers phospholipase C activation, leading to inositol 1,4,5-trisphosphate (IP3) generation and subsequent calcium mobilization from intracellular stores. Calcium imaging studies in GHSR-1a-expressing cell lines show rapid, transient calcium responses following ipamorelin application.

The compound exhibits partial agonist properties in some cellular contexts, with maximal responses reaching 60-80% of full agonist controls depending on cell line and experimental conditions. This pharmacological profile suggests functional selectivity at GHSR-1a, potentially influencing downstream effector pathway engagement.

Signaling Pathway Analysis

Calcium-Dependent Signaling Cascades

Ipamorelin-induced calcium mobilization activates multiple downstream signaling pathways in cell culture models. Protein kinase C (PKC) activation occurs secondary to diacylglycerol formation, leading to phosphorylation of substrate proteins including MARCKS and specific transcription factors. Real-time monitoring of intracellular calcium concentrations reveals biphasic response patterns, with initial rapid release followed by sustained calcium entry through voltage-operated channels.

Calcium-calmodulin dependent signaling pathways become activated following ipamorelin treatment, as demonstrated through calmodulin kinase II autophosphorylation assays. These pathways contribute to transcriptional regulation of growth hormone-related genes in appropriate cell model systems.

cAMP Pathway Interactions

While GHSR-1a primarily couples to Gq/11 pathways, ipamorelin demonstrates weak adenylyl cyclase activation in certain cell lines. Cyclic adenosine monophosphate (cAMP) measurements show modest increases following compound application, likely through Gs protein coupling or crosstalk mechanisms. Protein kinase A (PKA) substrate phosphorylation occurs at higher ipamorelin concentrations, indicating potential secondary pathway engagement.

Cell Model Applications

Heterologous Expression Systems

Chinese hamster ovary (CHO) cells stably transfected with human GHSR-1a serve as primary model systems for ipamorelin pharmacological characterization. These cells demonstrate robust receptor expression levels and consistent functional responses across passage numbers. Calcium flux assays in CHO-GHSR-1a cells provide reliable dose-response relationships for potency determinations.

Human embryonic kidney (HEK-293) cells transiently transfected with GHSR-1a offer alternative model systems for mechanistic studies. These cells support detailed signaling pathway analysis through their amenability to various reporter gene systems and biochemical assays.

Primary Cell Culture Models

Pituitary adenoma cell lines expressing endogenous GHSR-1a receptors provide physiologically relevant model systems for ipamorelin research. These cells maintain hormone secretion capabilities and demonstrate appropriate receptor-effector coupling mechanisms. Growth hormone release assays in these cellular models confirm functional receptor activation following ipamorelin treatment.

Enzyme Kinetics and Binding Kinetics

Association and dissociation rate constants for ipamorelin binding to GHSR-1a demonstrate characteristic kinetic profiles. Temperature-dependent binding studies reveal activation energy requirements consistent with protein-ligand interaction models. Scatchard plot analysis confirms single-site binding behavior with binding capacity proportional to receptor expression levels.

Research Summary

Ipamorelin demonstrates selective GHSR-1a receptor pharmacology through high-affinity binding and preferential Gq/11-mediated signaling pathway activation. The compound exhibits partial agonist properties with distinct calcium mobilization profiles in cell-based assay systems. These pharmacological characteristics make ipamorelin valuable for investigating growth hormone axis regulation mechanisms and GHSR-1a receptor function in controlled laboratory environments. Continued research applications focus on detailed signaling pathway mapping and receptor-effector coupling mechanisms in various cell model systems.

All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.

Hexarelin

TB-500

Epithalon

Ipamorelin

Tirzepatide

CJC-1295 DAC

PT-141

Semaglutide

Selank

BPC-157

Sermorelin

Melanotan 2

IGF LR3

Tesamorelin

AICAR

IGF-DES

GHRP 2

Albuterol

Tamoxifen

Letrozole

Clomiphene

Tadalafil

Clenbuterol

Anastrozole

Finasteride

Exemestane

Sildenafil

Yohimbine

Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows

Already a customer? Sign In

Create Account

All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.

ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.

Sarms

Stacks

Research Liquids

Albuterol 5MG/ML | 30ML with dropper

Anastrozole 1.5MG/ML | 30ML with dropper

Clomiphene 50MG/ML | 30ML with dropper

Finasteride 5MG/ML | 30ML with dropper

Letrozole 3.5 MG/ML | 30ML with dropper

LiquiCia 30MG/ML | 30ML with dropper

LiquiCia T50 50MG/ML | 30ML with dropper

LiquiClen 200MCG/ML | 30ML with dropper

Liquistane / Exemestane 25MG/ML | 30ML with dropper

LiquiTamo 20MG/ML | 30ML with dropper

LiquiVia 25MG/ML | 30 ML with dropper

T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper

Toremifene Citrate 60MG/ML | 30ML with dropper

Yohimbine HCL 10MG/ML | 30ML with dropper

Research Peptides

Aicar 50MG

BPC-157 + TB-500 Blend 2mg ea/ 4MG

BPC-157 5MG

CJC-1295 + DAC 2MG

CJC-1295 | No DAC 2MG

Epithalon 10MG

Frag Premium 176-191 5MG

GHK-CU Copper Peptide 50MG

GHRP-2 5MG

GHRP-6 5MG

Hexarelin 5MG

IGF-1 DES 1MG

IGF-1 LR3 1MG

Ipamorelin 5MG

Melanotan 2 10MG

NAD+ 500MG

PT-141 / Bremelanotide 10MG

GLP-1/GIP/GCG (RT)

Selank 5MG

GLP1 (SM)

Sermorelin 5MG

TB-500 5MG

GIP/GLP-1 (TZ)

PDE5 Inhibitors

GLP-1

Diluents

Bacteriostatic Water 10ML